Cargando…

The Gut Microbiome and Metastatic Renal Cell Carcinoma

The introduction of targeted therapy (TT) and immuno-oncology (IO) agents have revolutionized the treatment of metastatic renal cell carcinoma (mRCC). However, despite the significant improvements in survival and clinical response yielded by these agents, a significant percentage of patients still e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meza, Luis, Feng, Matthew, Lee, Kyle, Sperandio, Rubens, Pal, Sumanta Kumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960560/ https://www.ncbi.nlm.nih.gov/pubmed/36836036 http://dx.doi.org/10.3390/jcm12041502

Ejemplares similares

Live bacterial supplementation for improving treatment response in metastatic renal cell carcinoma
por: Meza, Luis, et al.
Publicado: (2022)

Therapeutic Sequencing in Metastatic Renal Cell Carcinoma
por: Maia, Manuel Caitano, et al.
Publicado: (2017)

Treatment Options in Metastatic Renal Cell Carcinoma: Focus on mTOR Inhibitors
por: Pal, Sumanta Kumar, et al.
Publicado: (2010)

Randomized trial assessing impact of probiotic supplementation on gut microbiome and clinical outcome from targeted therapy in metastatic renal cell carcinoma
por: Dizman, Nazli, et al.
Publicado: (2020)

The role of gut microbiome in immune modulation in metastatic renal cell carcinoma
por: Deluce, Jasna, et al.
Publicado: (2022)

Lessons from bamboo‐eating pandas and their gut microbiome: Gut microbiome flow and applications
por: Zhang, Zheng, et al.
Publicado: (2020)

Role of the Gut Microbiome in Vertebrate Evolution
por: Sharpton, Thomas J.
Publicado: (2018)

Circulating cytokines associated with clinical response to systemic therapy in metastatic renal cell carcinoma
por: Chehrazi-Raffle, Alexander, et al.
Publicado: (2021)

COVID-19 and the Gut Microbiome: More than a Gut Feeling
por: van der Lelie, Daniel, et al.
Publicado: (2020)

Concomitant Radioembolization and Immune Checkpoint Inhibition in Metastatic Renal Cell Carcinoma
por: Adashek, Jacob J., et al.
Publicado: (2018)

Considering the Other Half of the Gut Microbiome: Bacteriophages
por: Maurice, Corinne F.
Publicado: (2019)

How to Treat Renal Cell Carcinoma: The Current Treatment Landscape and Cardiovascular Toxicities
por: Castro, Daniela V., et al.
Publicado: (2022)

Implication of gut microbiome in age-related macular degeneration
por: Luo, Wendy, et al.
Publicado: (2023)

Gut microbiome immaturity and childhood acute lymphoblastic leukaemia
por: Peppas, Ioannis, et al.
Publicado: (2023)

The Clash of Microbiomes: From the Food Matrix to the Host Gut
por: Kiousi, Despoina Eugenia, et al.
Publicado: (2022)

Disease-Specific Survival in De Novo Metastatic Renal Cell Carcinoma in the Cytokine and Targeted Therapy Era
por: Pal, Sumanta K., et al.
Publicado: (2013)

Targeting Endoglin to Treat Metastatic Renal Cell Carcinoma: Lessons from Osler‐Weber‐Rendu Syndrome
por: Hahn, Andrew W., et al.
Publicado: (2018)

Microbial Eukaryotes: a Missing Link in Gut Microbiome Studies
por: Laforest-Lapointe, Isabelle, et al.
Publicado: (2018)

Role of the gut microbiome in chronic diseases: a narrative review
por: Vijay, Amrita, et al.
Publicado: (2021)

Gut microbiome: a balancing act between degeneration and regeneration
por: Saksena, Nitin, et al.
Publicado: (2022)

(Poly)phenolic compounds and gut microbiome: new opportunities for personalized nutrition
por: Narduzzi, Luca, et al.
Publicado: (2022)

Liver-Gut-Interaction: Role of Microbiome Transplantation in the Future Treatment of Metabolic Disease
por: Stadlbauer, Vanessa
Publicado: (2023)

The gut microbiome: a missing link in understanding the gastrointestinal manifestations of COVID-19?
por: Brooks, Erin F., et al.
Publicado: (2021)

Perspective: Nutritional Strategies Targeting the Gut Microbiome to Mitigate COVID-19 Outcomes
por: Daoust, Laurence, et al.
Publicado: (2021)

Imaging Response to Contemporary Immuno-oncology Combination Therapies in Patients With Metastatic Renal Cell Carcinoma
por: Navani, Vishal, et al.
Publicado: (2022)

Balancing efficacy and quality of life measurements among metastatic renal cell carcinoma (RCC) studies
por: Aragon-Ching, Jeanny B.
Publicado: (2021)

Vitamins as regulators of calcium-containing kidney stones — new perspectives on the role of the gut microbiome
por: Chmiel, John A., et al.
Publicado: (2023)

Front-Line Therapy for Metastatic Renal Cell Carcinoma: A Perspective on the Current Algorithm and Future Directions
por: Govindarajan, Ameish, et al.
Publicado: (2022)

Renal cell carcinoma: An update for the practicing urologist
por: Pal, Sumanta K., et al.
Publicado: (2015)

Towards Personalized Sampling in Clear Cell Renal Cell Carcinomas
por: Manini, Claudia, et al.
Publicado: (2022)

Characterizing the outcomes of metastatic papillary renal cell carcinoma
por: Connor Wells, John, et al.
Publicado: (2017)

Assessment of Treatment Patterns for Metastatic Renal Cell Carcinoma in Brazil
por: Bergerot, Paulo G., et al.
Publicado: (2017)

The therapeutic potential of HIF-2 antagonism in renal cell carcinoma
por: Cuvillier, Olivier
Publicado: (2017)

Where Next for Microbiome Research?
por: Waldor, Matthew K., et al.
Publicado: (2015)

Counterbalancing COVID-19 with Cancer Surveillance and Therapy: A Survey of Patients with Renal Cell Carcinoma
por: Staehler, Michael, et al.
Publicado: (2021)

The impact of insurance status on progression-free survival (PFS) and overall survival (OS) in patients with metastatic renal cell carcinoma (mRCC)
por: Castro, Daniela, et al.
Publicado: (2023)

COVID-19 and financial toxicity in patients with renal cell carcinoma
por: Staehler, Michael D., et al.
Publicado: (2020)

Non-Clear Cell Renal Cell Carcinoma: Current Management and Best Practice
por: Salgia, Meghan, et al.
Publicado: (2017)

Microbiome Research: Open Communication Today, Microbiome Applications in the Future
por: Schelkle, Bettina, et al.
Publicado: (2020)

Ultrasensitive Circulating Tumor DNA Pilot Study Distinguishes Complete Response and Partial Response With Immunotherapy in Patients With Metastatic Renal Cell Carcinoma
por: Chehrazi-Raffle, Alexander, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gaj8qcupmvavf38hrosllnbun7